Impact of Vitamin D3, Omega-3, and Exercise on Serum Sclerostin and Bone Markers
Overview
In a 3-year randomized controlled trial involving healthy older adults, a simple home-based strength exercise program (SHEP) alone or combined with omega-3 fatty acids significantly reduced serum sclerostin levels. Vitamin D3 and omega-3 supplementation alone did not significantly affect sclerostin or bone turnover markers P1NP and β-CTx.
Background
Osteoporosis is a prevalent skeletal disorder in older adults characterized by reduced bone mass and increased fracture risk. Sclerostin is a natural inhibitor of the Wnt signaling pathway, which promotes bone formation, making it a target for osteoporosis treatment. While pharmacological sclerostin inhibition improves bone mineral density, the effects of nonpharmacological interventions such as vitamin D3, omega-3 fatty acids, and exercise on serum sclerostin and bone metabolism remain unclear. Bone turnover markers like P1NP and β-CTx are used to assess bone remodeling but have shown inconsistent responses to these interventions.
Data Highlights
Intervention
Effect on Sclerostin (pmol/L)
Significance (P value)
Vitamin D3 alone
No significant change
NS
Omega-3 alone
No significant change
NS
SHEP vs Control Exercise
−1.56 (−2.54, −0.58)
0.002
Omega-3 + SHEP vs No Omega-3 + Control Exercise
−1.93 (−3.31, −0.54)
0.007
Effects on P1NP and β-CTx
No significant changes for any treatment
NS
Key Findings
SHEP significantly decreased serum sclerostin levels compared to control exercise.
Combination of omega-3 supplementation with SHEP further enhanced sclerostin reduction.
Vitamin D3 supplementation alone did not significantly alter serum sclerostin levels.
Neither vitamin D3, omega-3s, nor SHEP affected bone turnover markers P1NP and β-CTx significantly.
The study population consisted of largely vitamin D replete, physically active older adults.
Clinical Implications
Incorporating simple home-based strength exercises may beneficially modulate sclerostin levels and potentially influence bone formation pathways in older adults. Omega-3 supplementation may augment the effects of exercise on sclerostin but does not independently affect bone turnover markers. Vitamin D3 supplementation alone may not impact sclerostin or bone remodeling in vitamin D replete individuals, suggesting targeted interventions based on baseline status may be necessary.
Conclusion
This trial demonstrates that strength exercise, alone or combined with omega-3 fatty acids, reduces serum sclerostin levels in healthy older adults, whereas vitamin D3 and omega-3 supplementation alone do not significantly affect sclerostin or bone turnover markers. These findings support exercise as a key nonpharmacological strategy to influence bone metabolism in aging populations.
References
DO-HEALTH Trial Investigators 2024 -- Impact of Vitamin D3, Omega-3 Fatty Acids, and Physical Activity on Serum Sclerostin Concentrations and Bone Metabolism Indicators
by Elena Tsourdi, Stephanie Gängler, Melanie Kistler-Fischbacher, Martina Rauner, Bess Dawson-Hughes, E John Orav, Li-Tang Tsai, Wei Lang, John A Kanis, Robert Theiler, Andreas Egli, Heike A Bischoff-Ferrari, Lorenz C Hofbauer, on behalf of the DO-HEALTH Research Group
